Table 2 Summary of secondary outcomes

1) Proportion of FSWs at risk of HIV transmission among HIV positives

2) Proportion of FSWs at risk of HIV acquisition among HIV negatives

3) Proportion of HIV-infected women who are infectious (viral load > 1000copies/μL)

4) Proportion of FSWs reporting always using condoms with clients in last month who have laboratory evidence of STI

5) Proportion of FSWs reporting always using condoms with clients in last month who have evidence of Y chromosome in vaginal specimen

6) Proportion of FSW who have evidence of

 a. HIV testing in the last 6 months (among those now self-reporting HIV positivity)

 b. Having attended the Sisters clinic in the last 3 months

 c. Pre-exposure prophylaxis for HIV negatives

 d. Antiretroviral therapy for HIV positives

7) Proportion of all FSWs who know HIV status (i.e. are diagnosed HIV positive or were tested HIV negative in last 6 months)

8) Proportion of those taking ART who have (viral load > 1000 copies/μL) who have drug resistance